HLS ASX: Australian Clinical labs, the No.3 player in Australia's pathology market, withdrew a takeover bid for No.2 player Healius after the ACCC blocked a merger, but has not given up entirely.

Australian Clinical Labs, the No.3 player in the pathology market, has not given up in its chase for ailing No.2 player Healius.

Related Keywords

Australia ,Australian ,Jenny Macdonald ,John Wylie ,Agilex Biolabs ,Stephen Ridgeway , ,Sonic Healthcare ,Dorevitch Pathology ,Laverty Pathology ,Abbott Pathology ,